Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hannah Y, Wen"'
Autor:
Varadan Sevilimedu, Denise Frosina, Carlos Henrique dos Anjos, Hong Zhang, Sujata Patil, Anne Grabenstetter, Achim A. Jungbluth, Raza S Hoda, Jorge S. Reis-Filho, Edi Brogi, Mark E. Robson, Britta Weigelt, Tiffany A. Traina, Hannah Y Wen
Publikováno v:
American Journal of Surgical Pathology. 45:1274-1281
Immunotherapy for the treatment of programmed death-ligand 1 (PD-L1) positive locally advanced or metastatic triple negative breast cancer may benefit patients with metaplastic breast cancer (MpBC). Previous study of PD-L1 in MpBC scored tumor cells
Autor:
Caroline Bouzin, Serdar Altinay, Gaëtan MacGrogan, Serena Wong, Anne Vincent-Salomon, Claudia Maria Stanciu-Pop, Laurent Arnould, Franceska Dedeurwaerdere, Delfyne Hastir, Alberto Ravarino, Stephen B. Fox, Valérie Duwel, Caterina Marchiò, Hannah Y Wen, Renata Sinke, Dieter Peeters, Clara Gerosa, Emily Reisenbichler, Benjamin F. Dessauvagie, Maschenka Balkenhol, Magali Lacroix-Triki, Aline François, Christine Galant, Carolien H.M. van Deurzen, S Sanati, Kathleen Lambein, Octavio Burguès, Eline Kurpershoek, Sharon Nofech-Mozes, Andoni Laka, Anne-Sophie Van Rompuy, Mieke R Van Bockstal, Abeer M Shaaban, Glenn Broeckx, Cecile Colpaert, Vera R. J. Schelfhout, Shabnam Jaffer, Anne Marie Schelfhout, Maria Dolores Martin Martinez, Koen Van de Vijver, Erika Resetkova, Giuseppe Floris
Publikováno v:
MODERN PATHOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Modern Pathology, 34, 2130-2140
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Modern pathology
Modern pathology, Vol. 34, no.12, p. 2130-2140 (2021)
Modern Pathology, 34(12), 2130-2140. Nature Publishing Group
Modern Pathology, 34, 12, pp. 2130-2140
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Modern Pathology, 34, 2130-2140
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Modern pathology
Modern pathology, Vol. 34, no.12, p. 2130-2140 (2021)
Modern Pathology, 34(12), 2130-2140. Nature Publishing Group
Modern Pathology, 34, 12, pp. 2130-2140
Contains fulltext : 245198.pdf (Publisher’s version ) (Closed access) High stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC) are associated with pathological complete response (pCR) after neoadjuvant chemotherap
Publikováno v:
Arch Pathol Lab Med
Context.— Invasive micropapillary carcinoma (IMPC) is a rare variant of breast carcinoma, composed of avascular morula-like tumor clusters surrounded by stromal spaces, which can affect the HER2 immunohistochemical (IHC) staining pattern. The 2013
Autor:
Emad A. Rakha, Elaine Zhong, Dilip Giri, Laura C. Collins, Juan P. Palazzo, John R. Lozada, Jorge S. Reis-Filho, Fresia Pareja, Malcolm Hayes, Hannah Y Wen, Achim A. Jungbluth, Denise Frosina, Melinda E. Sanders, Britta Weigelt, Felipe C Geyer, Timothy M. D'Alfonso, Yunn-Yi Chen, Edi Brogi, Rohit Bhargava, Fatemeh Derakhshan, Thais Basili, Stuart J. Schnitt, Gregor Krings, Arnaud Da Cruz Paula, Edaise M da Silva, Syed A. Hoda
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol 33, iss 6
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol 33, iss 6
Tall cell carcinoma with reverse polarity is a rare subtype of breast carcinoma with solid and papillary growth and nuclear features reminiscent of those of the tall cell variant of papillary thyroid carcinoma. These tumors harbor recurrent IDH2 R172
Autor:
Dara S. Ross, Hannah Y Wen, Edi Brogi, Jorge S. Reis-Filho, Pier Selenica, Christopher J Schwartz, Britta Weigelt, Edaise M da Silva, Fresia Pareja
Publikováno v:
Mod Pathol
The SWI/SNF family of proteins is a multisubunit ATPase complex frequently altered in human cancer. Inactivating mutations in SWI/SNF-related matrix-associated actin-dependent regulator of chromatin (SMARCs) underpin a subset of tumors such as the ma
Autor:
Edaise M, da Silva, Francisco, Beca, Ana Paula Martins, Sebastiao, Melissa P, Murray, Catarina, Silveira, Arnaud, Da Cruz Paula, Fresia, Pareja, Hannah Y, Wen, Timothy M, D'Alfonso, Marcia, Edelweiss, Britta, Weigelt, Edi, Brogi, Jorge S, Reis-Filho, Hong, Zhang
Publikováno v:
Journal of Clinical Pathology
Aims Here we explore the presence of mediator complex subunit 12 (MED12) exon 2 and telomerase reverse transcriptase (TERT) promoter hotspot mutations in complex fibroadenomas (CFAs) of the breast. Methods The stromal components from 18 CFAs were sub
Autor:
Raza S, Hoda, Edi, Brogi, Jin, Xu, Katia, Ventura, Dara S, Ross, Chau, Dang, Mark, Robson, Larry, Norton, Monica, Morrow, Hannah Y, Wen
Publikováno v:
Archives of pathologylaboratory medicine. 144(5)
The American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline in breast cancer was updated in 2018 to address issues on interpretation of uncommon results using dual-probe in situ hybridization according to the 201
Autor:
Hannah Y Wen, Gulisa Turashvili, Edi Brogi, Maura N. Dickler, Clifford A. Hudis, Monica Morrow, Larry Norton
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
BMC Cancer
BMC Cancer
Background The 21-gene recurrence score (RS) assay determines the benefit of adding chemotherapy to endocrine therapy for patients with early stage, estrogen receptor (ER)-positive, HER2-negative breast cancer. The RS risk groups predict the likeliho
Autor:
Maura N. Dickler, Clifford A. Hudis, Monica Morrow, Edi Brogi, Gulisa Turashvili, Larry Norton, Hannah Y Wen
Publikováno v:
Breast Cancer Research and Treatment. 165:65-76
The 21-gene recurrence score (RS) assay predicts the likelihood of distant recurrence and chemotherapy benefit in early-stage, estrogen receptor (ER)-positive, HER2-negative breast cancer. Data on the RS of special histologic subtypes of invasive bre
Autor:
Gulisa Turashvili, Monica Gonzalez-Loperena, Edi Brogi, Larry Norton, Maura N. Dickler, Hannah Y Wen, Monica Morrow
BACKGROUND: Given the limited data, systemic treatment of male breast cancer has been extrapolated from female patients. The 21-gene recurrence score (RS) assay estimates the risk of distant recurrence and chemotherapy benefit in early-stage, ER+/HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b707ee7bf11db68fbe49c58c32cc44
https://europepmc.org/articles/PMC5930124/
https://europepmc.org/articles/PMC5930124/